Becton Dickinson and Co

Market Summary

USD232.29-1.25

Market Closed

-0.54%

BDX Alerts

1 major insider sales recently.
Big fall in earnings (Y/Y)

BDX Stock Price

View Fullscreen

BDX RSI Chart

BDX Alerts

1 major insider sales recently.
Big fall in earnings (Y/Y)

BDX Valuation

Market Cap

71.3B

Price/Earnings (Trailing)

44.09

Price/Sales (Trailing)

3.79

EV/EBITDA

15.66

Price/Free Cashflow

72.01

BDX Price/Sales (Trailing)

BDX Profitability

EBT Margin

9.46%

Return on Equity

6.42%

Return on Assets

3.14%

Free Cashflow Yield

1.39%

BDX Fundamentals

BDX Revenue

Revenue (TTM)

19.4B

Revenue Y/Y

6.85%

Revenue Q/Q

4.28%

BDX Earnings

Earnings (TTM)

1.5B

Earnings Y/Y

-62.5%

Earnings Q/Q

-73.46%

Price Action

Last 7 days

-1.1%

Last 30 days

-8.8%

Last 90 days

-12.5%

Trailing 12 Months

-4.5%

How does BDX drawdown profile look like?

BDX Financial Health

Current Ratio

1.25

BDX Investor Care

Dividend Yield

1.54%

Diluted EPS (TTM)

4.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	18.8B	19.0B	19.4B	0
2022	18.7B	18.7B	18.9B	18.7B
2021	18.9B	19.6B	19.4B	18.8B
2020	17.4B	16.9B	17.1B	18.2B
2019	17.0B	17.1B	17.3B	17.4B
2018	13.5B	14.7B	16.0B	17.1B
2017	12.3B	12.2B	12.1B	12.3B
2016	12.2B	12.3B	12.5B	12.4B
2015	8.5B	9.4B	10.3B	11.2B
2014	8.2B	8.3B	8.4B	8.5B
2013	7.8B	7.9B	8.1B	8.2B
2012	7.6B	7.7B	7.7B	7.8B
2011	7.2B	7.3B	7.6B	7.6B
2010	7.2B	7.2B	7.1B	7.1B
2009	6.9B	6.9B	7.0B	7.1B
2008	6.6B	6.7B	6.9B	6.9B
2007	0	0	6.3B	6.4B

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for BDX

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Nov 28, 2023	byrd richard	sold	-514,141	238	-2,156	evp & president interventional
Nov 26, 2023	mocherla pavan kumar	acquired	-	-	751	evp & president greater asia
Nov 26, 2023	shan david	sold (taxes)	-	-	-149	evp and chief isc officer
Nov 26, 2023	quinn michelle	sold (taxes)	-	-	-440	evp and general counsel
Nov 26, 2023	mocherla pavan kumar	sold (taxes)	-	-	-64.00	evp & president greater asia
Nov 26, 2023	goette roland	sold (taxes)	-	-	-213	evp and president emea
Nov 26, 2023	byrd richard	acquired	-	-	4,341	evp & president interventional
Nov 26, 2023	delorefice christopher	sold (taxes)	-	-	-812	evp & chief financial officer
Nov 26, 2023	spoerel thomas j	sold (taxes)	-	-	-365	svpcontroller & chief acct off
Nov 26, 2023	hickey david	acquired	-	-	1,663	evp & president, life sciences

Which funds bought or sold BDX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Dec 06, 2023	CITIGROUP INC	reduced	-4.06	-3,591,230	55,781,600	0.04%
Dec 06, 2023	Grant Street Asset Management, Inc.	reduced	-0.1	-5,749	258,785	0.10%
Dec 06, 2023	VisionPoint Advisory Group, LLC	unchanged	-	-186	8,790	-%
Dec 06, 2023	Fragasso Group Inc.	reduced	-3.69	-32,232	532,726	0.06%
Dec 04, 2023	TUCKER ASSET MANAGEMENT LLC	unchanged	-	-510	24,043	0.01%
Dec 04, 2023	Phoenix Holdings Ltd.	new	-	1,415,320	1,415,320	0.01%
Dec 04, 2023	Trust Co	reduced	-59.18	-7,765	5,171	-%
Dec 01, 2023	PFS Partners, LLC	unchanged	-	-271	15,379	0.01%
Dec 01, 2023	B. Riley Wealth Advisors, Inc.	reduced	-65.83	-4,375,490	2,200,400	0.06%
Dec 01, 2023	Fortis Group Advisors, LLC	added	0.36	-30,162	482,296	0.15%

Latest Funds Activity

Are funds buying BDX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own BDX

No. of Funds

Schedule 13G FIlings of Becton Dickinson and Co

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	price t rowe associates inc /md/	6.7%	18,962,386	SC 13G/A
Feb 09, 2023	vanguard group inc	8.94%	25,421,347	SC 13G/A
Feb 07, 2023	blackrock inc.	8.4%	23,781,609	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	7.0%	20,016,331	SC 13G
Feb 09, 2022	vanguard group inc	8.48%	24,176,366	SC 13G/A
Feb 08, 2022	blackrock inc.	7.5%	21,348,508	SC 13G/A
Feb 16, 2021	price t rowe associates inc /md/	4.2%	12,347,992	SC 13G/A
Feb 10, 2021	vanguard group inc	8.38%	24,360,444	SC 13G/A
Feb 08, 2021	fmr llc	-	0	SC 13G/A
Feb 05, 2021	blackrock inc.	7.9%	22,926,497	SC 13G/A

Recent SEC filings of Becton Dickinson and Co

View All Filings

Date Filed	Form Type	Document
Nov 29, 2023	4	Insider Trading
Nov 28, 2023	144	Notice of Insider Sale Intent
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading
Nov 28, 2023	4	Insider Trading

Peers (Alternatives to Becton Dickinson and Co)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.1B	40.0B	9.79%	-0.70%	35.09	4.53	-11.26%	-34.57%
BDX	71.3B	19.4B	-8.82%	-4.53%	44.09	3.79	2.66%	-16.58%
BAX	18.5B	15.0B	6.81%	-29.70%	7.13	1.23	3.01%	209.09%
ALGN	16.6B	3.8B	9.66%	15.63%	45.73	4.36	-1.48%	-28.97%
MID-CAP
HSIC	9.3B	12.7B	13.63%	-12.11%	20.89	0.73	0.68%	-30.25%
BIO	9.0B	2.7B	2.35%	-23.26%	-56.61	3.32	-3.01%	97.36%
ATR	8.3B	3.4B	1.55%	18.98%	29.56	2.41	3.13%	18.17%
XRAY	6.9B	3.9B	14.40%	9.17%	-31.57	1.75	-2.62%	73.28%
AXNX	2.9B	342.6M	8.31%	-12.22%	-244.83	8.56	42.19%	84.14%
PDCO	2.5B	6.6B	-12.97%	-7.64%	12.41	0.38	2.61%	0.62%
SMALL-CAP
AHCO	1.1B	3.1B	3.77%	-63.31%	-2.53	0.35	7.95%	-550.16%
ANIK	329.0M	163.3M	7.10%	-27.48%	-13.39	2.01	7.14%	-56.09%
ANGO	282.7M	335.9M	6.52%	-42.04%	43.86	0.84	4.71%	116.39%
APYX	72.1M	50.3M	-18.43%	13.66%	-4.75	1.43	3.23%	20.81%
AEMD	5.2M	3.8M	8.25%	-44.93%	-0.45	1.37	17.30%	10.67%

Becton Dickinson and Co News

Latest updates

Nasdaq • 08 Dec 2023 • 09:00 pm • 62 minutes ago

Validea Detailed Fundamental Analysis - BDX

InvestorsObserver • 21 Nov 2023 • 08:00 am • 17 days ago

Is Becton Dickinson and Co (BDX) a Stock to Watch After Gaining 1.00% This Week?

Best Stocks • 13 Nov 2023 • 09:37 pm • 25 days ago

Becton Dickinsons Short Interest Decreases Indicating Shift in ...

Smartkarma • 09 Nov 2023 • 08:00 am • 29 days ago

Becton Dickinson and Co (BDX) Earnings Surpass Estimates with ...

Mass Device • 02 Nov 2023 • 07:00 am • 36 days ago

BD launches next-gen needle-free blood draw tech

Yahoo Finance • 23 Oct 2023 • 07:00 am • 46 days ago

The Zacks Analyst Blog Highlights Apple, Amgen, Becton, Dickinson ...

The Market Periodical • 18 Oct 2023 • 07:00 am • 51 days ago

Becton, Dickinson and Co.: Will BDX Stock Bounce Back to $267?

CNBC • 20 Sep 2023 • 07:00 am • 2 months ago

Cramer's Lightning Round: Carrier Global is 'terrific'

CNBC • 08 Aug 2023 • 07:00 am • 4 months ago

Cramer's Lightning Round: Pass on Crocs

Yahoo Finance • 03 Aug 2023 • 07:00 am • 4 months ago

Becton Dickinson: Fiscal Q3 Earnings Snapshot

Mass Device • 01 Aug 2023 • 07:00 am • 4 months ago

FDA clears BD combo test for COVID-19, flu, RSV

Reuters • 25 Jul 2023 • 07:00 am • 4 months ago

Becton Dickinson shares hit record high after US FDA clears return ...

Mass Device • 25 Jul 2023 • 07:00 am • 4 months ago

BD adds former J&J chief medical officer to its board

Yahoo Finance • 24 Jul 2023 • 07:00 am • 4 months ago

Is Becton, Dickinson and Co (BDX) Stock Modestly Overvalued? An ...

Yahoo Finance • 24 Jul 2023 • 07:00 am • 4 months ago

Chevron, Becton Dickinson, Domino's Pizza rise; Spotify falls ...

Financials for Becton Dickinson and Co

Income Statement (Last 12 Months)
(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Revenue	4.3%	5,087	4,878	4,821	4,586	4,761	4,641	4,750	4,718	4,576	4,607	4,907	5,315	4,784	3,855	4,253	4,225	4,584	4,350	4,195	4,160	4,402
Costs and Expenses	9.4%	4,738	4,329	4,193	4,001	4,272	4,104	4,185	4,027	4,345	4,114	4,473	4,074	4,057	3,497	3,884	3,724	4,474	3,725	4,059	3,273	3,827
S&GA Expenses	-4.4%	1,138	1,190	1,205	1,187	1,183	1,149	1,192	1,185	1,254	1,200	1,148	1,149	1,059	980	1,025	1,121	1,094	1,076	1,089	1,073	1,101
R&D Expenses	-8.2%	281	306	337	313	300	315	327	314	355	330	317	291	243	262	264	270	270	282	252	258	277
EBITDA Margin	-100.0%	-	0.24*	0.24*	0.23*	0.23*	0.25*	0.24*	0.24*	0.25*	0.24*	0.24*	0.24*	0.21*	0.21*	0.22*	0.21*	0.24*	0.27*	0.28*	0.28*	-
Interest Expenses	-5.0%	113	119	118	102	104	99.00	97.00	98.00	112	115	124	118	123	135	134	136	141	156	171	171	181
Income Taxes	-56.2%	28.00	64.00	68.00	-28.00	33.00	31.00	52.00	32.00	-24.00	-28.00	6.00	154	-34.00	-38.00	17.00	117	-164	9.00	-17.00	115	550
Earnings Before Taxes	-61.6%	181	471	529	481	320	421	442	600	2.00	378	305	1,157	-428	248	200	394	-1.50	460	3.00	714	415
EBT Margin	-100.0%	-	0.09*	0.09*	0.09*	0.09*	0.11*	0.11*	0.10*	0.11*	0.10*	0.10*	0.10*	0.06*	0.05*	0.06*	0.05*	0.07*	0.09*	0.10*	0.10*	-
Net Income	-73.5%	108	407	460	509	288	360	454	677	265	525	299	1,003	128	286	183	278	163	451	20.00	599	-135
Net Income Margin	-100.0%	-	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.10*	0.10*	0.09*	0.09*	0.05*	0.05*	0.06*	0.05*	0.07*	0.05*	0.06*	0.06*	-
Free Cashflow	-100.0%	-	890	4.00	191	658	137	217	486	462	732	935	1,287	1,268	660	261	540	1,013	695	587	78.00	-

Balance Sheet
(In Millions)

Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	-0.4%	52,780	53,017	54,394	53,129	52,934	53,199	54,786	53,363	53,866	54,333	54,921	54,748	54,012	53,959	53,516	51,952	51,765	52,233	52,598	52,932	53,904
Current Assets	1.0%	8,676	8,588	9,587	8,175	8,141	9,547	10,152	8,307	8,838	9,538	10,000	9,537	8,969	8,827	8,555	6,438	6,664	6,781	6,844	6,941	7,411
Cash Equivalents	60.5%	1,481	923	1,981	612	1,006	2,759	3,320	2,047	2,392	3,282	3,898	3,447	2,917	2,964	2,439	609	590	594	767	1,042	1,236
Inventory	-8.8%	3,273	3,588	3,656	3,604	3,224	3,163	3,258	3,035	2,743	2,947	2,895	2,814	2,743	2,945	2,793	2,760	2,579	2,629	2,627	2,522	2,451
Net PPE	1.3%	6,557	6,474	6,356	6,247	6,012	6,005	6,406	6,384	6,003	6,164	6,142	6,096	5,923	5,841	5,664	5,782	5,659	5,550	5,473	5,362	5,375
Goodwill	-0.3%	24,522	24,584	24,780	24,763	24,621	23,968	24,096	24,116	23,886	23,814	23,772	23,758	23,604	23,549	23,415	23,435	23,376	23,498	23,513	23,505	23,600
Current Liabilities	-3.4%	6,641	6,878	7,304	7,625	7,811	7,080	6,657	6,735	6,626	7,749	5,376	7,021	5,836	6,067	8,755	6,726	5,655	6,237	7,108	7,145	7,216
LT Debt, Non Current	-1.3%	14,738	14,926	16,010	14,268	13,886	14,683	17,584	16,360	17,110	15,700	17,718	16,082	17,224	17,090	16,809	16,949	18,081	18,016	17,556	17,817	18,894
Shareholder's Equity	-0.5%	25,796	25,937	25,689	25,472	25,282	25,493	24,525	24,160	23,677	24,135	24,826	24,663	23,765	24,022	20,951	21,202	21,081	21,497	21,309	21,404	20,994
Retained Earnings	-1.0%	15,535	15,691	15,563	15,384	15,157	15,088	14,416	14,233	13,826	13,821	13,557	13,522	12,791	12,916	12,868	12,938	12,913	12,997	12,792	13,018	12,596
Additional Paid-In Capital	0.2%	19,720	19,681	19,639	19,590	19,553	19,511	19,495	19,435	19,272	19,282	19,341	19,301	19,270	19,228	16,288	16,320	16,270	16,227	16,177	16,174	16,179
Accumulated Depreciation	0.3%	7,021	7,002	6,848	6,679	6,402	6,399	6,788	6,648	6,090	6,487	6,277	6,177	5,996	5,819	5,598	5,643	5,469	5,491	5,402	5,223	5,111

Cashflow (Last 12 Months)
(In Millions)

Cashflow (Quarterly)
Description	(%) Q/Q	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Cashflow From Operations	22.6%	1,325,000,000	1,081,000,000	185,000,000	399,000,000	973,000,000	678,000,000	290,000,000	530,000,000	841,000,000	564,000,000	1,188,000,000	1,533,000,000	879,000,000	862,000,000	483,000,000	713,000,000	1,371,000,000	932,000,000	782,000,000	245,000,000	1,306,000,000
Share Based Compensation	3.6%	58,000,000	56,000,000	56,000,000	89,000,000	49,000,000	50,000,000	53,000,000	81,000,000	47,000,000	44,000,000	55,000,000	83,000,000	43,000,000	52,000,000	59,000,000	82,000,000	53,000,000	56,000,000	59,000,000	93,000,000	61,000,000
Cashflow From Investing	141.6%	137,000,000	-329,000,000	-233,000,000	-291,000,000	-2,005,000,000	-236,000,000	-297,000,000	-682,000,000	-681,000,000	-299,000,000	-433,000,000	-430,000,000	-285,000,000	-363,000,000	-255,000,000	-287,000,000	-441,000,000	-330,000,000	-269,000,000	299,000,000	-560,000,000
Cashflow From Financing	44.4%	-997,000,000	-1,794,000,000	1,369,000,000	-534,000,000	-549,000,000	-846,000,000	986,000,000	-327,000,000	-1,142,000,000	-1,271,000,000	-301,000,000	-592,000,000	-1,208,000,000	20,000,000	1,623,000,000	-413,000,000	-923,000,000	-768,000,000	-798,000,000	-734,000,000	-1,007,000,000
Dividend Payments	-100.0%	-	286,000,000	282,000,000	281,000,000	270,000,000	271,000,000	270,000,000	271,000,000	259,000,000	261,000,000	264,000,000	264,000,000	253,000,000	268,000,000	253,000,000	252,000,000	247,000,000	246,000,000	246,000,000	245,000,000	240,000,000
Buy Backs	-	-	-	-	-	500,000,000	-	-	-	750,000,000	-	-	-	-	-	-	-	-	-	-	-	-

BDX Income Statement

2023-09-30

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenues	$ 19,372	$ 18,870	$ 19,131
Cost of products sold	11,202	10,393	10,500
Selling and administrative expense	4,719	4,709	4,719
Research and development expense	1,237	1,256	1,279
Acquisition-related integration and restructuring expense	313	192	179
Other operating (income) expense, net	(210)	37	203
Total Operating Costs and Expenses	17,261	16,588	16,881
Operating Income	2,111	2,282	2,250
Interest expense	(452)	(398)	(469)
Interest income	49	16	9
Other expense, net	(46)	(117)	(99)
Income from Continuing Operations Before Income Taxes	1,662	1,783	1,692
Income tax provision	132	148	88
Net Income from Continuing Operations	1,530	1,635	1,604
(Loss) Income from Discontinued Operations, Net of Tax	(46)	144	488
Net Income	1,484	1,779	2,092
Preferred stock dividends	(60)	(90)	(90)
Net income applicable to common shareholders	$ 1,424	$ 1,689	$ 2,002
Basic Earnings per Share
Income (Loss) from Continuing Operations, Per Basic Share	$ 5.14	$ 5.42	$ 5.23
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share	(0.16)	0.50	1.69
Earnings Per Share, Basic	4.97	5.93	6.92
Diluted Earnings per Share
Income (Loss) from Continuing Operations, Per Diluted Share	5.10	5.38	5.18
Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share	(0.16)	0.50	1.67
Diluted Earnings per Share (USD per share)	$ 4.94	$ 5.88	$ 6.85

BDX Balance Sheet

2023-09-30

Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Sep. 30, 2022
Current Assets
Cash and equivalents	$ 1,416	$ 1,006
Restricted cash	65	153
Short-term investments	8	8
Trade receivables, net	2,534	2,191
Inventories	3,273	3,224
Prepaid expenses and other	1,380	1,559
Total Current Assets	8,676	8,141
Property, Plant and Equipment, Net	6,557	6,012
Goodwill	24,522	24,621
Developed Technology, Net	8,058	9,108
Customer Relationships, Net	2,338	2,683
Other Intangibles, Net	552	519
Other Assets	2,078	1,848
Total Assets	52,780	52,934
Current Liabilities
Current debt obligations	1,141	2,179
Accounts payable	1,641	1,699
Accrued expenses	2,604	2,605
Salaries, wages and related items	1,115	1,171
Income taxes	139	157
Total Current Liabilities	6,641	7,811
Long-Term Debt	14,738	13,886
Long-Term Employee Benefit Obligations	1,023	902
Deferred Income Taxes and Other Liabilities	4,582	5,052
Commitments and Contingencies
Shareholders’ Equity
Preferred Stock, Value, Issued	0	2
Common Stock, Value, Issued	371	365
Capital in excess of par value	19,720	19,553
Retained earnings	15,535	15,157
Deferred compensation	24	23
Treasury Stock, Value	(8,305)	(8,330)
Accumulated other comprehensive loss	(1,548)	(1,488)
Total Shareholders’ Equity	25,796	25,282
Total Liabilities and Shareholders’ Equity	$ 52,780	$ 52,934

About Becton Dickinson and Co

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

CEO	Mr. Thomas E. Polen Jr.
WEBSITE	www.bd.com
EMPLOYEES	65535

Becton Dickinson and Co Frequently Asked Questions

What is the ticker symbol for Becton Dickinson and Co? What does BDX stand for in stocks?

BDX is the stock ticker symbol of Becton Dickinson and Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Becton Dickinson and Co (BDX)?

As of Thu Dec 07 2023, market cap of Becton Dickinson and Co is 71.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BDX stock?

You can check BDX's fair value in chart. The fair value of Becton Dickinson and Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Becton Dickinson and Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BDX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Becton Dickinson and Co a good stock to buy?

The fair value guage provides a quick view whether BDX is over valued or under valued. Whether Becton Dickinson and Co is cheap or expensive depends on the assumptions which impact Becton Dickinson and Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BDX.

What is Becton Dickinson and Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, BDX's PE ratio (Price to Earnings) is 44.09 and Price to Sales (PS) ratio is 3.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BDX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Becton Dickinson and Co's stock?

In the past 10 years, Becton Dickinson and Co has provided 0.097 (multiply by 100 for percentage) rate of return.

Market Summary

BDX Alerts

BDX Stock Price

BDX RSI Chart

BDX Alerts

BDX Valuation

BDX Price/Sales (Trailing)

BDX Profitability

BDX Fundamentals

BDX Revenue

BDX Earnings

Price Action

How does BDX drawdown profile look like?

BDX Financial Health

BDX Investor Care

Historical Charts for Stock Metrics

Latest Insider Trading transactions for BDX

Which funds bought or sold BDX recently?

Latest Funds Activity

Schedule 13G FIlings of Becton Dickinson and Co

Recent SEC filings of Becton Dickinson and Co

Peers (Alternatives to Becton Dickinson and Co)

Becton Dickinson and Co News

Financials for Becton Dickinson and Co

Income Statement (Last 12 Months).css-zgnqz2{margin:0;font-family:"Roboto","Helvetica","Arial",sans-serif;font-weight:400;font-size:0.75rem;line-height:1.66;letter-spacing:0.03333em;color:#595959;}(In Millions)

Balance Sheet(In Millions)

Cashflow (Last 12 Months)(In Millions)

BDX Income Statement

BDX Balance Sheet

About Becton Dickinson and Co

Becton Dickinson and Co Frequently Asked Questions

What is the ticker symbol for Becton Dickinson and Co? What does BDX stand for in stocks?

What is the market capital of Becton Dickinson and Co (BDX)?

What is the fair value of BDX stock?

Is Becton Dickinson and Co a good stock to buy?

What is Becton Dickinson and Co's Price to Earnings (PE) and Price to sales (PS) ratio?

What is 5 year return on Becton Dickinson and Co's stock?

Income Statement (Last 12 Months)
(In Millions)

Balance Sheet
(In Millions)

Cashflow (Last 12 Months)
(In Millions)